arrow
M

Matthijs D. Linssen

university medical center groningen
H指数:16
被引数:1,491

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of Clinical-Grade Durvalumab-680LT and Nivolumab-800CW for Multispectral Fluorescent Imaging of the PD-1/PD-L1 Axis of the Immune Checkpoint Pathway

开发临床级Durvalumab-680LT和Nivolumab-800CW用于免疫检查点通路PD-1/PD-L1轴的多光谱荧光成像

2025-10-070
OAAI
Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial

出版商更正: 转移性黑色素瘤的个性化自体新抗原特异性T细胞治疗: 1期试验

2025-08-040
OA
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial

个性化自体新抗原特异性T细胞疗法在转移性黑色素瘤中的应用:一项1期临床试验

2025-01-031
OA
EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial
2023-08-1625
OAAI
Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study
2020-01-0171
OAAI
Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer
2019-10-1840
OAAI
Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe
2017-12-2637
OAAI
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
2017-05-31216
OAAI
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer
2017-01-3135
OAAI
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study
2016-12-01143
OAAI